These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 28738891)

  • 1. Pivotal trials of orthopedic surgical devices in the United States: predominance of two-arm non-inferiority designs.
    Golish SR
    Trials; 2017 Jul; 18(1):348. PubMed ID: 28738891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal devices in the United States-investigational device exemption trials and premarket approval of class III devices.
    Golish SR; Reed ML
    Spine J; 2017 Jan; 17(1):150-157. PubMed ID: 27737804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM; Rathi VK; Grauer JN; Ross JS
    Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of FDA-Approved Orthopaedic Devices and Their Recalls.
    Day CS; Park DJ; Rozenshteyn FS; Owusu-Sarpong N; Gonzalez A
    J Bone Joint Surg Am; 2016 Mar; 98(6):517-24. PubMed ID: 26984921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research: Evaluation of Orthopedic Hip Device Recalls by the FDA from 2007 to 2017.
    Peters W; Pellerin C; Janney C
    Biomed Instrum Technol; 2020 Nov; 54(6):418-426. PubMed ID: 33339030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiological Medical Device Innovation: Approvals via the Premarket Approval Pathway From 2000 to 2015.
    Ghobadi CW; Hayman EL; Finkle JH; Walter JR; Xu S
    J Am Coll Radiol; 2017 Jan; 14(1):24-33. PubMed ID: 28061962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017.
    Dubin JR; Simon SD; Norrell K; Perera J; Gowen J; Cil A
    JAMA Netw Open; 2021 May; 4(5):e217274. PubMed ID: 33956132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
    Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
    Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US FDA Advisory Panel Members' Assessment of Premarket Approval Process and Suggestions for Improvement.
    Alam M; Shi VJ; Maisel-Campbell A; Cressey BD; Nadir U; Koza E; Haq M; Ahmed A; Ma MS; Weil A; Cahn BA; Lee AY; Shapiro S; Poon E
    JAMA Netw Open; 2024 Oct; 7(10):e2436066. PubMed ID: 39382899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity in Medical Device Clinical Trials: Do We Know What Works for Which Patients?
    Fox-Rawlings SR; Gottschalk LB; Doamekpor LA; Zuckerman DM
    Milbank Q; 2018 Sep; 96(3):499-529. PubMed ID: 30203600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthopedic devices; reclassification of the intervertebral body fusion device. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jun; 72(112):32170-2. PubMed ID: 17632942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals.
    Geraghty PJ; Matsumura JS; Conte MS
    J Vasc Surg; 2009 Dec; 50(6):1459-61. PubMed ID: 19897333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical device recalls and the FDA approval process.
    Zuckerman DM; Brown P; Nissen SE
    Arch Intern Med; 2011 Jun; 171(11):1006-11. PubMed ID: 21321283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interconnected Ancestral Network of Hip Arthroplasty Device Approval.
    Premkumar A; Zhu A; Ying X; Pean CA; Sheth NP; Cross MB; Gonzalez Della Valle A
    J Am Acad Orthop Surg; 2021 Dec; 29(24):e1362-e1369. PubMed ID: 34161960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports.
    Chang L; Dhruva SS; Chu J; Bero LA; Redberg RF
    BMJ; 2015 Jun; 350():h2613. PubMed ID: 26063311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study.
    Hwang TJ; Sokolov E; Franklin JM; Kesselheim AS
    BMJ; 2016 Jun; 353():i3323. PubMed ID: 27352914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Device Recalls in Radiation Oncology: Analysis of US Food and Drug Administration Data, 2002-2015.
    Connor MJ; Tringale K; Moiseenko V; Marshall DC; Moore K; Cervino L; Atwood T; Brown D; Mundt AJ; Pawlicki T; Recht A; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):438-446. PubMed ID: 28463163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA.
    Swanson MJ; Johnston JL; Ross JS
    Trials; 2021 Nov; 22(1):817. PubMed ID: 34789308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.